Tangen Biosciences, Inc.
Formerly Tangen Biosciences, LLC
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Tangen Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2020).
SEC Form D · Jul 2020
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2020
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Tangen Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brian Chirico | Executive officer | Jul 2020 |
| John Davidson | Executive officer | Jul 2020 |
| Richard Birkmeyer, PhD | Executive officer | Jul 2020 |
| John Richard Davidson | Executive officer | Dec 2015 |
| John Richard Nobile | Executive officer | Dec 2015 |
| Christopher Benoit | Director | Jul 2020 |
| Christopher McLeod | Director | Jul 2020 |
| Dan Wagner | Director | Jul 2020 |
| John Davidson | Director | Jul 2020 |
| Richard Birkmeyer, PhD | Director | Jul 2020 |
| John Richard Davidson | Director | Dec 2015 |
| John Richard Nobile | Director | Dec 2015 |
| John Richard Davidson | Promoter | Dec 2015 |
| John Richard Nobile | Promoter | Dec 2015 |